Thoma Jeanne 4

What Happened
Jeanne Thoma, a director of ANI Pharmaceuticals, received a restricted stock award of 4,357 shares on May 21, 2026. The shares were reported at $0.00 per share (no cash purchase price reported). According to the filing, the award will vest in full on May 21, 2027. This is a grant/compensation event rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-21; Filing (Form 4) date: 2026-06-10 (filed late relative to the 2-business-day rule).
• Transaction type/code: A — Award/Grant (restricted stock award).
• Shares acquired: 4,357 at $0.00 per share (no cash paid).
• Vesting: Will vest in full on 2027-05-21 (per footnote).
• Shares owned after the transaction: Not specified in the provided filing.
• No 10b5-1, tax-withholding, or cashless sale noted in the filing.

Context
Restricted stock awards are a common form of director/employee compensation and typically carry vesting and transfer restrictions until the vesting date; they do not by themselves signal a buy or sell decision by the insider. The filing was submitted notably late (filed ~20 days after the grant date), which can affect timeliness transparency but does not change the underlying grant terms.